Lymphangioma — Trials

Lymphangioma — Trials · CancerIndex

Clinical trials

Registered studies

11 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05983159	A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations(TARGET-VM)	recruiting	Phase 2	50	Murdoch Childrens Research InstituteOTHER	1	May 5, 2026	clinicaltrials
NCT07477548	A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular Anomalies	not yet recruiting	Phase 2	67	Yonsei UniversityOTHER	0	Mar 17, 2026	clinicaltrials
NCT00975819	Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies	completed	Phase 2	61	Denise Martin AdamsOTHER	1	Jan 6, 2026	clinicaltrials
NCT05050149	Study Evaluating the Safety and Efficacy of PTX-022 (QTORIN Sirolimus) in the Treatment of Microcystic Lymphatic Malformations

Data updated 22 days agoSource updated May 5, 2026source: clinicaltrials